You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
|
|---|---|
| Published in |
Frontiers in Pharmacology, January 2021
|
| DOI | 10.3389/fphar.2020.621054 |
| Pubmed ID | |
| Authors |
Andrey A. Poloznikov, Stepan A. Nersisyan, Dmitry M. Hushpulian, Eliot H. Kazakov, Alexander G. Tonevitsky, Sergey V. Kazakov, Valery I. Vechorko, Sergey V. Nikulin, Julia A. Makarova, Irina G. Gazaryan |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 10% |
| Maldives | 1 | 10% |
| India | 1 | 10% |
| Switzerland | 1 | 10% |
| Unknown | 6 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 80% |
| Scientists | 2 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 72 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 19% |
| Student > Ph. D. Student | 8 | 11% |
| Other | 5 | 7% |
| Student > Master | 5 | 7% |
| Student > Bachelor | 3 | 4% |
| Other | 8 | 11% |
| Unknown | 29 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 13 | 18% |
| Biochemistry, Genetics and Molecular Biology | 10 | 14% |
| Agricultural and Biological Sciences | 4 | 6% |
| Neuroscience | 3 | 4% |
| Engineering | 2 | 3% |
| Other | 6 | 8% |
| Unknown | 34 | 47% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 July 2023.
All research outputs
#5,246,639
of 25,761,363 outputs
Outputs from Frontiers in Pharmacology
#2,479
of 20,003 outputs
Outputs of similar age
#138,228
of 537,962 outputs
Outputs of similar age from Frontiers in Pharmacology
#101
of 584 outputs
Altmetric has tracked 25,761,363 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,003 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 537,962 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 584 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.